Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell publishing date : 2021 - 01 - 19 save search
Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma
Published: 2021-01-19 (Crawled : 18:00) - biospace.com/
SNGX | $0.4012 -1.13% -1.15% 450K
|
Health Technology
|
| O: 0.98%
H: 21.19%
C: 15.65%
t-cell treatment commercialization
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Published: 2021-01-19 (Crawled : 12:07) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.74%
H: 1.8%
C: 1.27%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: 0.82%
H: 8.47%
C: 5.15%
collaboration t-cell antibody announces collaboration
Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
Published: 2021-01-19 (Crawled : 12:03) - globenewswire.com
DTIL | $10.33 6.72% 6.29% 31K
|
Health Technology
|
| O: 9.91%
H: 18.6%
C: 17.87%
fda fda acceptance car-t
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.